Published in J Bioenerg Biomembr on February 11, 2012
MCT1-mediated transport of a toxic molecule is an effective strategy for targeting glycolytic tumors. Nat Genet (2012) 1.70
Critical Role of Glucose Metabolism in Rheumatoid Arthritis Fibroblast-like Synoviocytes. Arthritis Rheumatol (2016) 1.50
VDAC1: from structure to cancer therapy. Front Oncol (2012) 1.16
Dysregulated metabolism contributes to oncogenesis. Semin Cancer Biol (2015) 1.03
Inhibition of glucose turnover by 3-bromopyruvate counteracts pancreatic cancer stem cell features and sensitizes cells to gemcitabine. Oncotarget (2014) 1.02
Molecular Connections between Cancer Cell Metabolism and the Tumor Microenvironment. Int J Mol Sci (2015) 0.99
Intracellular ion channels and cancer. Front Physiol (2013) 0.97
An integrated multidisciplinary model describing initiation of cancer and the Warburg hypothesis. Theor Biol Med Model (2013) 0.95
Targeting hexokinase II to mitochondria to modulate energy metabolism and reduce ischaemia-reperfusion injury in heart. Br J Pharmacol (2014) 0.93
Differentiate or Die: 3-Bromopyruvate and Pluripotency in Mouse Embryonic Stem Cells. PLoS One (2015) 0.86
Metabolic interplay between glycolysis and mitochondrial oxidation: The reverse Warburg effect and its therapeutic implication. World J Biol Chem (2015) 0.85
Safety and outcome of treatment of metastatic melanoma using 3-bromopyruvate: a concise literature review and case study. Chin J Cancer (2014) 0.79
3-Bromopyruvate induces rapid human prostate cancer cell death by affecting cell energy metabolism, GSH pool and the glyoxalase system. J Bioenerg Biomembr (2015) 0.78
The anticancer agent 3-bromopyruvate: a simple but powerful molecule taken from the lab to the bedside. J Bioenerg Biomembr (2016) 0.78
Reprogramming of glucose metabolism in hepatocellular carcinoma: Progress and prospects. World J Gastroenterol (2016) 0.77
KRAS Mutant Pancreatic Cancer: No Lone Path to an Effective Treatment. Cancers (Basel) (2016) 0.77
Metabolic targeting of oncogene MYC by selective activation of the proton-coupled monocarboxylate family of transporters. Oncogene (2015) 0.77
Effect of 3-bromopyruvate acid on the redox equilibrium in non-invasive MCF-7 and invasive MDA-MB-231 breast cancer cells. J Bioenerg Biomembr (2015) 0.77
MUC1-mediated metabolic alterations regulate response to radiotherapy in pancreatic cancer. Clin Cancer Res (2017) 0.76
The energy blockers 3-bromopyruvate and lonidamine: effects on bioenergetics of brain mitochondria. J Bioenerg Biomembr (2014) 0.76
Glutathione may have implications in the design of 3-bromopyruvate treatment protocols for both fungal and algal infections as well as multiple myeloma. Oncotarget (2016) 0.76
Inhibition of hexokinase-2 with targeted liposomal 3-bromopyruvate in an ovarian tumor spheroid model of aerobic glycolysis. Int J Nanomedicine (2015) 0.76
Lactate/pyruvate transporter MCT-1 is a direct Wnt target that confers sensitivity to 3-bromopyruvate in colon cancer. Cancer Metab (2016) 0.76
Metabolic enzymes: key modulators of functionality in cancer stem-like cells. Oncotarget (2017) 0.75
Glucose metabolic phenotype of pancreatic cancer. World J Gastroenterol (2016) 0.75
The effect of 3-bromopyruvate on human colorectal cancer cells is dependent on glucose concentration but not hexokinase II expression. Biosci Rep (2016) 0.75
Selected polyphenols potentiate the apoptotic efficacy of glycolytic inhibitors in human acute myeloid leukemia cell lines. Regulation by protein kinase activities. Cancer Cell Int (2016) 0.75
ITD mutation in FLT3 tyrosine kinase promotes Warburg effect and renders therapeutic sensitivity to glycolytic inhibition. Leukemia (2017) 0.75
Impaired mitochondrial functions contribute to 3-bromopyruvate toxicity in primary rat and mouse hepatocytes. J Bioenerg Biomembr (2016) 0.75
On respiratory impairment in cancer cells. Science (1956) 14.07
Tumor mitochondria and the bioenergetics of cancer cells. Prog Exp Tumor Res (1978) 3.16
Hexokinase-2 bound to mitochondria: cancer's stygian link to the "Warburg Effect" and a pivotal target for effective therapy. Semin Cancer Biol (2008) 2.93
Warburg, me and Hexokinase 2: Multiple discoveries of key molecular events underlying one of cancers' most common phenotypes, the "Warburg Effect", i.e., elevated glycolysis in the presence of oxygen. J Bioenerg Biomembr (2007) 2.47
Advanced cancers: eradication in all cases using 3-bromopyruvate therapy to deplete ATP. Biochem Biophys Res Commun (2004) 2.29
High aerobic glycolysis of rat hepatoma cells in culture: role of mitochondrial hexokinase. Proc Natl Acad Sci U S A (1977) 2.20
Glucose catabolism in the rabbit VX2 tumor model for liver cancer: characterization and targeting hexokinase. Cancer Lett (2001) 2.11
Bromopyruvate inactivation of 2-keto-3-deoxy-6-phosphogluconic aldolase. I. Kinetic evidence for active site specificity. Biochemistry (1967) 1.30
The pivotal roles of mitochondria in cancer: Warburg and beyond and encouraging prospects for effective therapies. Biochim Biophys Acta (2010) 1.22
The cancer cell's "power plants" as promising therapeutic targets: an overview. J Bioenerg Biomembr (2007) 1.09
Alkylation of isocitrate lyase from Escherichia coli by 3-bromopyruvate. Arch Biochem Biophys (1990) 0.99
Use of chemical modification in the crystallization of isocitrate lyase from Escherichia coli. J Mol Biol (1991) 0.88
A kinetic study on the inactivation of 3-deoxy-D-arabino-heptulosonate 7-phosphate synthase by bromopyruvate. Biochim Biophys Acta (1967) 0.82
Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation. J Clin Invest (2000) 5.48
Tumor mitochondria and the bioenergetics of cancer cells. Prog Exp Tumor Res (1978) 3.16
Infarct remodeling after intracoronary progenitor cell treatment in patients with acute myocardial infarction (TOPCARE-AMI): mechanistic insights from serial contrast-enhanced magnetic resonance imaging. Circulation (2003) 2.97
Hexokinase II: cancer's double-edged sword acting as both facilitator and gatekeeper of malignancy when bound to mitochondria. Oncogene (2006) 2.96
Lysophospholipids--receptor revelations. Science (2001) 2.61
Dual actions of sphingosine-1-phosphate: extracellular through the Gi-coupled receptor Edg-1 and intracellular to regulate proliferation and survival. J Cell Biol (1998) 2.54
Identification of the SAAT gene involved in strawberry flavor biogenesis by use of DNA microarrays. Plant Cell (2000) 2.52
Preparation and characterization of mitochondria and submitochondrial particles of rat liver and liver-derived tissues. Methods Cell Biol (1978) 2.51
Chlamydia pneumoniae (TWAR) in atherosclerosis of the carotid artery. Circulation (1995) 2.24
Defective protein folding as a basis of human disease. Trends Biochem Sci (1995) 2.22
High aerobic glycolysis of rat hepatoma cells in culture: role of mitochondrial hexokinase. Proc Natl Acad Sci U S A (1977) 2.20
Assessment of Crohn's disease activity by Doppler sonography of the superior mesenteric artery, clinical evaluation and the Crohn's disease activity index: a prospective study. Clin Radiol (2001) 2.14
Glucose catabolism in the rabbit VX2 tumor model for liver cancer: characterization and targeting hexokinase. Cancer Lett (2001) 2.11
Adenosine triphosphatase from rat liver mitochondria. I. Purification, homogeneity, and physical properties. J Biol Chem (1971) 2.04
The peripheral-type benzodiazepine receptor. Localization to the mitochondrial outer membrane. J Biol Chem (1986) 2.03
Ligand-induced trafficking of the sphingosine-1-phosphate receptor EDG-1. Mol Biol Cell (1999) 2.02
Percutaneous internal ureteral stent placement: review of technical issues and solutions in 50 consecutive cases. Clin Radiol (1994) 2.01
Glutathione S-transferase mu modulates the stress-activated signals by suppressing apoptosis signal-regulating kinase 1. J Biol Chem (2001) 1.99
Functional significance of mitochondrial bound hexokinase in tumor cell metabolism. Evidence for preferential phosphorylation of glucose by intramitochondrially generated ATP. J Biol Chem (1988) 1.97
Differential coupling of the sphingosine 1-phosphate receptors Edg-1, Edg-3, and H218/Edg-5 to the G(i), G(q), and G(12) families of heterotrimeric G proteins. J Biol Chem (1999) 1.90
Blood and urine levels of tea catechins after ingestion of different amounts of green tea by human volunteers. Cancer Epidemiol Biomarkers Prev (1998) 1.87
Psoriasis: a possible risk factor for development of coronary artery calcification. Br J Dermatol (2007) 1.86
Biphosphonate-induced osteonecrosis of the jaws: CT and MRI spectrum of findings in 32 patients. Clin Radiol (2007) 1.84
Glucose catabolism in cancer cells: identification and characterization of a marked activation response of the type II hexokinase gene to hypoxic conditions. J Biol Chem (2001) 1.84
Variables affecting the risk of pneumothorax and intrapulmonal hemorrhage in CT-guided transthoracic biopsy. Eur Radiol (2008) 1.83
Glucose catabolism in cancer cells. The type II hexokinase promoter contains functionally active response elements for the tumor suppressor p53. J Biol Chem (1997) 1.83
Abnormal regulation of high affinity nicotinic receptors in subjects with schizophrenia. Neuropsychopharmacology (2000) 1.77
Determination of microgram quantities of protein in the presence of milligram levels of lipid with amido black 10B. Anal Biochem (1985) 1.75
Sphingosine 1-phosphate activates Akt, nitric oxide production, and chemotaxis through a Gi protein/phosphoinositide 3-kinase pathway in endothelial cells. J Biol Chem (2001) 1.72
Sphingosine 1-phosphate-induced endothelial cell migration requires the expression of EDG-1 and EDG-3 receptors and Rho-dependent activation of alpha vbeta3- and beta1-containing integrins. J Biol Chem (2001) 1.70
The CAT-Tox (L) assay: a sensitive and specific measure of stress-induced transcription in transformed human liver cells. Fundam Appl Toxicol (1995) 1.70
Absorption, distribution, elimination of tea polyphenols in rats. Drug Metab Dispos (1997) 1.69
Interface ferromagnetism and orbital reconstruction in BiFeO3-La(0.7)Sr(0.3)MnO3 heterostructures. Phys Rev Lett (2010) 1.68
Cardiovascular and Interventional Radiological Society of Europe commentary on the treatment of chronic cerebrospinal venous insufficiency. Cardiovasc Intervent Radiol (2010) 1.66
Energy metabolism of tumor cells. Requirement for a form of hexokinase with a propensity for mitochondrial binding. J Biol Chem (1981) 1.63
Smoking and mental illness. Pharmacol Biochem Behav (2001) 1.63
Efficacy and safety of the angioseal vascular closure device post antegrade puncture. Cardiovasc Intervent Radiol (2008) 1.61
The use of EUS to diagnose malignant portal venous system invasion by pancreatic cancer. Gastrointest Endosc (1996) 1.59
Characterization of adrenal masses using unenhanced CT: an analysis of the CT literature. AJR Am J Roentgenol (1998) 1.57
Aberrant glycolytic metabolism of cancer cells: a remarkable coordination of genetic, transcriptional, post-translational, and mutational events that lead to a critical role for type II hexokinase. J Bioenerg Biomembr (1997) 1.57
The diagnostic accuracy of magnetic resonance cholangiopancreatography and ultrasound compared with direct cholangiography in the detection of choledocholithiasis. Clin Radiol (1999) 1.53
Focal liver lesions: MR imaging with Mn-DPDP--initial clinical results in 40 patients. Radiology (1992) 1.53
Proton atpases: structure and mechanism. Annu Rev Biochem (1983) 1.52
Treatment of continuous data as categoric variables in Obstetrics and Gynecology. Obstet Gynecol (1997) 1.52
Changes in blood flow velocity and diameter of the middle cerebral artery during hyperventilation: assessment with MR and transcranial Doppler sonography. AJNR Am J Neuroradiol (1998) 1.50
Characterization of indeterminate (lipid-poor) adrenal masses: use of washout characteristics at contrast-enhanced CT. Radiology (2000) 1.50
Imaging patients with "post-cholecystectomy syndrome": an algorithmic approach. Clin Radiol (2005) 1.50
Crossing ureteric strictures: microcatheters to the rescue when conventional methods fail. Cardiovasc Intervent Radiol (2007) 1.49
Hexokinase receptor complex in hepatoma mitochondria: evidence from N,N'-dicyclohexylcarbodiimide-labeling studies for the involvement of the pore-forming protein VDAC. Biochemistry (1986) 1.49
State-of-the-art adrenal imaging. Radiographics (2001) 1.49
The first nucleotide binding fold of the cystic fibrosis transmembrane conductance regulator can function as an active ATPase. J Biol Chem (1995) 1.48
[MR-guided biopsies of undetermined liver lesions: technique and results]. Rofo (2003) 1.47
Early surgical débridement of symptomatic pancreatic necrosis is beneficial irrespective of infection. Am J Surg (1992) 1.46
Difference in direct charge-parity violation between charged and neutral B meson decays. Nature (2008) 1.46
Lipoma and liposarcoma: evaluation using CT and MR imaging. AJR Am J Roentgenol (1997) 1.44
Interventional radiology of the pleural space. Clin Radiol (1995) 1.44
Sphingosine-1-phosphate: extracellular mediator or intracellular second messenger? Biochem Pharmacol (1999) 1.44
Metal artifact reduction sequence: early clinical applications. Radiographics (2000) 1.43
[Laser-induced Interstitial thermotherapy (LITT) in hepatic metastases of various sizes in an animal model]. Rofo (2005) 1.42
MR imaging features of bizarre parosteal osteochondromatous proliferation of bone (Nora's lesion). Eur J Radiol (2001) 1.38
Hepatic hemangiomas and malignant tumors: improved differentiation with heavily T2-weighted conventional spin-echo MR imaging. Radiology (1994) 1.37
Phosphate transport in rat liver mitochondria. Kinetics and energy requirements. J Biol Chem (1974) 1.35
Intestinal permeability correlates with severity of injury in trauma patients. J Trauma (1998) 1.33
A high-yield preparative method for isolation of rat liver mitochondria. Anal Biochem (1977) 1.32
Diagnostic accuracy of magnetic resonance cholangiopancreatography and ultrasound compared with direct cholangiography in the detection of choledocholithiasis. Clin Radiol (2000) 1.31
Contributions of glycolysis and oxidative phosphorylation to adenosine 5'-triphosphate production in AS-30D hepatoma cells. Cancer Res (1984) 1.30
The 2.8-A structure of rat liver F1-ATPase: configuration of a critical intermediate in ATP synthesis/hydrolysis. Proc Natl Acad Sci U S A (1998) 1.30
Rasmussen's aneurysm: a forgotten entity? Cardiovasc Intervent Radiol (2007) 1.29
Somatic mutation of TSSC5, a novel imprinted gene from human chromosome 11p15.5. Cancer Res (1998) 1.29
Glucose catabolism in cancer cells: amplification of the gene encoding type II hexokinase. Cancer Res (1996) 1.29
Structural identification of two metabolites of catechins and their kinetics in human urine and blood after tea ingestion. Chem Res Toxicol (2000) 1.28
Detection of pneumolysin in sputum. J Med Microbiol (1999) 1.27
Insulin-like growth factor II induced by hypoxia may contribute to angiogenesis of human hepatocellular carcinoma. Cancer Res (1998) 1.26
Biochemical and ultrastructural properties of a mitochondrial inner membrane fraction deficient in outer membrane and matrix activities. J Cell Biol (1970) 1.26
Cholangiographic segmental anatomy of the liver. Radiographics (1994) 1.25
Expression of Clarkia S-linalool synthase in transgenic petunia plants results in the accumulation of S-linalyl-beta-D-glucopyranoside. Plant J (2001) 1.25
Proton magnetic resonance spectroscopy in patients with glial tumors: a multicenter study. J Neurosurg (1996) 1.24
Specificity of detection of Chlamydia pneumoniae in cardiovascular atheroma: evaluation of the innocent bystander hypothesis. Am J Pathol (1997) 1.24
Glucose catabolism in cancer cells. Isolation, sequence, and activity of the promoter for type II hexokinase. J Biol Chem (1995) 1.24
Tea and tea polyphenols in cancer prevention. J Nutr (2000) 1.23
Imaging of soft tissue infections. Radiol Clin North Am (2001) 1.22
Automated procedure for candidate compound selection in GC-MS metabolomics based on prediction of Kovats retention index. Bioinformatics (2009) 1.22
Oxidative damage in an esophageal adenocarcinoma model with rats. Carcinogenesis (2000) 1.21
Assessment of breast cancer-related arm lymphedema--comparison of physical measurement methods and self-report. Cancer Invest (2010) 1.20
Intracellular localization and properties of particulate hexokinase in the Novikoff ascites tumor. Evidence for an outer mitochondrial membrane location. J Biol Chem (1983) 1.20
Glucose phosphorylation in tumor cells. Cloning, sequencing, and overexpression in active form of a full-length cDNA encoding a mitochondrial bindable form of hexokinase. J Biol Chem (1990) 1.20
Diethylstilbestrol. A novel F0-directed probe of the mitochondrial proton ATPase. J Biol Chem (1986) 1.19
Sensitive protein assay in presence of high levels of lipid. Methods Enzymol (1989) 1.19
Accuracy of CT in the diagnosis of allergic bronchopulmonary aspergillosis in asthmatic patients. AJR Am J Roentgenol (1999) 1.19
Measurement of the differential branching fraction and forward-backward asymmetry for B --> K(*)l+l-. Phys Rev Lett (2009) 1.17
Perfusion CT in squamous cell carcinoma of the upper aerodigestive tract: long-term predictive value of baseline perfusion CT measurements. AJNR Am J Neuroradiol (2009) 1.17
Interventional radiology in the diagnosis, management, and follow-up of pseudoaneurysms. Cardiovasc Intervent Radiol (2008) 1.16
Detection of the Staphylococcal mecA gene by chemiluminescent DNA hybridization. J Clin Microbiol (1995) 1.16
Cystic fibrosis transmembrane conductance regulator: nucleotide binding to a synthetic peptide. Science (1991) 1.15
A novel angiogenic factor derived from Aloe vera gel: beta-sitosterol, a plant sterol. Angiogenesis (1999) 1.14
Sustained, retransplantable, multilineage engraftment of highly purified adult human bone marrow stem cells in vivo. Blood (1996) 1.14
Plasma and tissue levels of tea catechins in rats and mice during chronic consumption of green tea polyphenols. Nutr Cancer (2000) 1.12
Routine chest radiographs after central line insertion: mandatory postprocedural evaluation or unnecessary waste of resources? Cardiovasc Intervent Radiol (1999) 1.12
Inhibition of gastric secretion in man by intestinal fat infusion. Gut (1969) 1.11